Cinclus Pharma is a research based biotech company developing small molecules for the treatment of gastric acid related diseases. Their main asset, X842, has been studied in a Phase I clinical trial. Cinclus Pharma is based in Basel, Switzerland.

Biotechnology

Clinical Trials

Pharmaceutical

Cinclus Pharma

Cinclus Pharma's headquarters in Mölndal, Sweden

Christer Ahlberg

Laura Truong

Kajsa Larsson

Jesper Wiklund

Magnus Christensen

Patrik Norgren

Kjell Andersson

Gösta Hiller

Nina Rawal

Helena Levander

Lennart Hansson

Wenche Rolfsén

Anders Öhberg

Torbjörn Koivisto

Peter Unge

The Advisory and Governance team at Cinclus Pharma is responsible for providing strategic guidance and oversight on key business decisions, ensuring compliance with regulatory standards, and facilitating stakeholder engagement. Comprised of experienced non-executive directors and co-founders, this team leverages their expertise to support the company's mission in developing innovative therapies for gastric acid-related diseases, particularly during critical phases such as clinical trials.

Advisory and Governance

The Leadership Team at Cinclus Pharma is responsible for shaping the strategic direction of the company and overseeing its operations. Comprising experienced professionals from diverse backgrounds, the team drives the development of innovative treatment solutions for gastric acid-related diseases, ensures financial sustainability, and guides clinical research, including the advancement of X842 through vital trial phases. Their collaborative leadership fosters a culture of scientific excellence and positions the company for successful growth in the biotech field.

Leadership Team

Cinclus Pharma

Org chart

Board & advisors

Teams

Advisory and Governance

Leadership Team

Offices

Cinclus Pharma

Org chart

Board & advisors

Teams

Advisory and Governance

Leadership Team

Offices

Related companies